Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualised MApping-Guided Ablation to Improve Outcomes in pErsistent Atrial Fibrillation

NCT05065112 is registered in ClinicalTrials.gov with Royal Brompton & Harefield NHS Foundation Trust as lead sponsor.

NCT NCT05065112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05065112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualised MApping-Guided Ablation to Improve Outcomes in pErsistent Atrial Fibrillation
Lead sponsor
Royal Brompton & Harefield NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2021
Completion date
May 31, 2025
Enrollment
212 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation